Imaging Science in Dentistry

Korean Academy of Oral and Maxillofacial Radiology (대한영상치의학회)
권호 표지
DOI QR코드

DOI QR Code

Mucormycosis-related osteomyelitis of the maxilla in a post-COVID-19 patient

  • Yun-Hui, Kang (Department of Oral and Maxillofacial Radiology, School of Dentistry, Seoul National University) ;
  • Sam-Sun, Lee (Department of Oral and Maxillofacial Radiology, School of Dentistry, Seoul National University) ;
  • Moe Thu Zar, Aung (Department of Oral and Maxillofacial Radiology, School of Dentistry, Seoul National University) ;
  • Ju-Hee, Kang (Department of Oral and Maxillofacial Radiology, Seoul National University Dental Hospital) ;
  • Jo-Eun, Kim (Department of Oral and Maxillofacial Radiology, School of Dentistry, Seoul National University) ;
  • Kyung-Hoe, Huh (Department of Oral and Maxillofacial Radiology, School of Dentistry, Seoul National University) ;
  • Min-Suk, Heo (Department of Oral and Maxillofacial Radiology, School of Dentistry, Seoul National University)
  • Received : 2022.08.08
  • Accepted : 2022.10.05
  • Published : 2022.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Mucormycosis is a rare, invasive fungal infection that progresses aggressively and requires prompt surgery and appropriate treatment. The number of cases of mucormycosis in coronavirus disease 2019 (COVID-19) patients has recently increased, and patients with uncontrolled diabetes mellitus are particularly at an elevated risk of infection. This report presents a case of mucormycosis-related osteomyelitis of the maxilla in a 37-year-old man with diabetes mellitus. The patient complained of severe and persistent pain in the right maxilla, accompanied by increased tooth mobility and headache. On contrast-enhanced computed tomographic images, gas-forming osteomyelitis of the right maxilla was observed. Destruction of the maxilla and palatine bone then proceeded aggressively. Sequestrectomy was performed on the right maxilla, and the histopathological diagnosis was mucormycosis. Further investigation after the first operation revealed the patient's history of COVID-19 infection.

Keywords

References

  1. Pal R, Singh B, Bhadada SK, Banerjee M, Bhogal RS, Hage N, et al. COVID-19-associated mucormycosis: an updated systematic review of literature. Mycoses 2021; 64: 1452-9. https://doi.org/10.1111/myc.13338
  2. Garg D, Muthu V, Sehgal IS, Ramachandran R, Kaur H, Bhalla A, et al. Coronavirus disease (COVID-19) associated mucormycosis(CAM): case report and systematic review of literature. Mycopathologia 2021; 186: 289-98. https://doi.org/10.1007/s11046-021-00528-2
  3. Dan M. Mucormycosis of the head and neck. Curr Infect Dis Rep 2011; 13: 123-31. https://doi.org/10.1007/s11908-010-0162-8
  4. Skiada A, Lass-Floerl C, Klimko N, Ibrahim A, Roilides E, Petrikkos G. Challenges in the diagnosis and treatment of mucormycosis. Med Mycol 2018; 56(suppl 1): 93-101.
  5. Said Ahmed WM, Elsherbini AM, Elsherbiny NM, El-Sherbiny M, Ramzy NI, Arafa AF. Maxillary mucormycosis osteomyelitis in post COVID-19 patients: a series of fourteen cases. Diagnostics(Basel) 2021; 11: 2050.
  6. Arafat Y, Kumar YN, Bharani K, Balaji TM, Varadarajan S, Raj T, et al. COVID-19-related mucormycotic osteomyelitis of the maxilla: a case report of findings, surgical management and post-surgical rehabilitation. World J Dent 2021; 12: 423-6. https://doi.org/10.5005/jp-journals-10015-1864
  7. Mendhe D, Wankhede P, Wanjari M, Alwadkar S. Mucormycotic osteomyelitis of maxilla post-COVID patient: a case report. Pan Afr Med J 2021; 39: 275.
  8. Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr 2021; 15: 102146.
  9. Fakhar M, Zakariaei Z, Sharifpour A, Banimostafavi ES, Pourmousa R, Soleymani M, et al. Post-COVID-19 maxillary osteonecrosis and floating maxillary teeth due to mucormycosis in two uncontrolled diabetic patients. Clin Case Rep 2022; 10: e05502.
  10. Gao YD, Ding M, Dong X, Zhang JJ, Kursat Azkur A, Azkur D, et al. Risk factors for severe and critically ill COVID-19 patients: a review. Allergy 2021; 76: 428-55. https://doi.org/10.1111/all.14657
  11. Small JE, Chea P, Shah N, Small KM. Diagnostic features of emphysematous osteomyelitis. Curr Probl Diagn Radiol 2022; 51: 666-72. https://doi.org/10.1067/j.cpradiol.2018.05.008
  12. Ram PC, Martinez S, Korobkin M, Breiman RS, Gallis HR, Harrelson JM. CT detection of intraosseous gas: a new sign of osteomyelitis. AJR Am J Roentgenol 1981; 137: 721-3. https://doi.org/10.2214/ajr.137.4.721
  13. Riley TT, Muzny CA, Swiatlo E, Legendre DP. Breaking the mold: a review of mucormycosis and current pharmacological treatment options. Ann Pharmacother 2016; 50: 747-57. https://doi.org/10.1177/1060028016655425
  14. Janjua OS, Shaikh MS, Fareed MA, Qureshi SM, Khan MI, Hashem D, et al. Dental and oral manifestations of COVID-19 related mucormycosis: diagnoses, management strategies and outcomes. J Fungi(Basel) 2021; 8: 44.
  15. Lewis RE, Kontoyiannis DP. Epidemiology and treatment of mucormycosis. Future Microbiol 2013; 8: 1163-75. https://doi.org/10.2217/fmb.13.78
  16. Huang JS, Kok SH, Lee JJ, Hsu WY, Chiang CP, Kuo YS. Extensive maxillary sequestration resulting from mucormycosis. Br J Oral Maxillofac Surg 2005; 43: 532-4. https://doi.org/10.1016/j.bjoms.2005.05.012
  17. Oswal NP, Gadre PK, Sathe P, Gadre KS. Mucormycosis of mandible with unfavorable outcome. Case Rep Dent 2012; 2012: 257940.
  18. Rahman QB, Rahaman MM, Imon AA, Rabby MA, Chowdhury MJ. Management of maxillary mucormycosis - a case report in Bangladesh. Med Today 2015; 27: 38-40. https://doi.org/10.3329/medtoday.v27i1.26000
  19. Park YL, Cho S, Kim JW. Mucormycosis originated total maxillary and cranial base osteonecrosis: a possible misdiagnosis to malignancy. BMC Oral Health 2021; 21: 65.
  20. John TM, Jacob CN, Kontoyiannis DP. When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis. J Fungi(Basel) 2021; 7: 298.
  21. Srivastava A, Mohpatra M, Mahapatra A. Maxillary fungal osteomyelitis: a review of literature and report of a rare case. Ann Maxillofac Surg 2019; 9: 168-73.
  22. Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SC, Dannaoui E, Hochhegger B, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis 2019; 19: e405-21. https://doi.org/10.1016/S1473-3099(19)30312-3
  23. Kontoyiannis DP, Lewis RE. How I treat mucormycosis. Blood 2011; 118: 1216-24. https://doi.org/10.1182/blood-2011-03-316430
  24. Suresh A, Joshi A, Desai AK, Juturu U, Kurian DJ, Jain P, et al. Covid-19-associated fungal osteomyelitis of jaws and sinuses: an experience-driven management protocol. Med Mycol 2022; 60: myab082.